4 in 10 Fractures in Breast Cancer Patients Are Pathologic
Breast cancer is associated with an increased fracture risk, attributed in part to estrogen deficiency, aromatase inhibitors frailty, and..
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.